Drug Shortage Report for CARBOLITH
Report ID | 244145 |
Drug Identification Number | 02011239 |
Brand name | CARBOLITH |
Common or Proper name | CARBOLITH |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LITHIUM CARBONATE |
Strength(s) | 600MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | n/a |
ATC code | N05AN |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-11-26 |
Estimated end date | 2024-12-16 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-11-28 | French | Compare |
v1 | 2024-11-28 | English | Compare |
Showing 1 to 2 of 2